Slideshow

New Products: Laser line offers dusting, fragmentation, ablation capabilities

Also read about expansions to an intermittent catheter line, a new radiofrequency treatment for improving local vaginal circulation, an app for men navigating fertility challenges, and more.

Related Videos
J. Quentin Clemens, MD, MSCI, answers a question during a video interview
Jeffrey A. Albaugh, PhD, APRN, CUCNS, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
A. Lenore Ackerman, MD, PhD, answers a question during a Zoom video interview
Hospital waiting room with reception counter at medical facility | Image Credit: © visoot - stock.adobe.com
Related Content
Key FDA decisions urologists can expect in the first half of 2025
January 28th 2025

Key FDA decisions urologists can expect in the first half of 2025

Hannah Clarke
Check out the key regulatory decisions set to happen early this year.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
In-depth study of microbiomes may lead to better UTI care for patients with spina bifida
January 6th 2025

In-depth study of microbiomes may lead to better UTI care for patients with spina bifida

Brendan T. Frainey, MD
"The goal for this study was to understand, over the lifetime in individuals with spina bifida, what bacteria are present in their urine normally, what bacteria are present when they have a UTI, and what are some important clinical differences we can tease out to help understand which patients should really be treated," says Brendan T. Frainey, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022

Destigmatizing Urology: Dr. Winter discusses STDs/STIs

Urology Times staff
“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy
November 1st 2024

ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy

Hannah Clarke
A rapid reduction in E coli in the urine was observed among 10 of 16 evaluable patients at 4 hours following the first treatment.
FDA approves oral sulopenem for uncomplicated urinary tract infection
Published: October 25th 2024 | Updated: October 25th 2024

FDA approves oral sulopenem for uncomplicated urinary tract infection

Hannah Clarke
The approval is supported by data from the phase 3 SURE 1 and REASSURE trials.
© 2025 MJH Life Sciences

All rights reserved.